Martijn Verdoes

5.7k total citations
95 papers, 4.2k citations indexed

About

Martijn Verdoes is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Martijn Verdoes has authored 95 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 35 papers in Oncology and 33 papers in Immunology. Recurrent topics in Martijn Verdoes's work include Ubiquitin and proteasome pathways (22 papers), Immunotherapy and Immune Responses (21 papers) and Peptidase Inhibition and Analysis (17 papers). Martijn Verdoes is often cited by papers focused on Ubiquitin and proteasome pathways (22 papers), Immunotherapy and Immune Responses (21 papers) and Peptidase Inhibition and Analysis (17 papers). Martijn Verdoes collaborates with scholars based in Netherlands, United States and Germany. Martijn Verdoes's co-authors include Matthew Bogyo, Herman S. Overkleeft, Laura E. Edgington‐Mitchell, Wouter A. van der Linden, Bogdan I. Florea, Nimali P. Withana, Floris J. van Dalen, Felix L. Fennemann, Huib Ovaa and Edgar Deu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Martijn Verdoes

92 papers receiving 4.1k citations

Peers

Countries citing papers authored by Martijn Verdoes

Since Specialization

Citations

This map shows the geographic impact of Martijn Verdoes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn Verdoes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn Verdoes more than expected).

Fields of papers citing papers by Martijn Verdoes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn Verdoes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn Verdoes. The network helps show where Martijn Verdoes may publish in the future.

Co-authorship network of co-authors of Martijn Verdoes

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn Verdoes. A scholar is included among the top collaborators of Martijn Verdoes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn Verdoes. Martijn Verdoes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cathepsin L-dependent positive selection shapes clonal composition and functional fitness of CD4+ T cells 2025 ·Nature Immunology ·(unknown), (unknown), (unknown), Christine Federle, Jelena Nedjic, Sarina Ravens, (unknown), Anna M. Schulz, Dietmar Zehn, Marc Schmidt‐Supprian, Reinhard Obst, Immo Prinz, Martijn Verdoes, Jan Kisielow, Thomas Reinheckel, Tobias Straub, Stephen R. Daley, Ludger Klein	1
2	trans-Cyclooctene-caged-IL-1β immunocytokine-constructs ligated to unmodified nanobodies allow click-2-release-based control of cytokine activity 2025 ·RSC Chemical Biology ·Arjan D. Barendrecht, Harald Peeters, Diana Torres‐García, (unknown), (unknown), (unknown), (unknown), Camille M. Le Gall, Martin Wilkovitsch, Martijn Verdoes, Hannes Mikula, Mark A. Travis, Sander I. van Kasteren	1
3	Semi‐Flexible Immunobrushes Facilitate Effective and Selective Expansion of Antigen‐Specific T Cells 2023 ·Advanced Functional Materials ·(unknown), L. Weiss, (unknown), (unknown), (unknown), (unknown), (unknown), Martijn Verdoes, Carl G. Figdor, Paul H. J. Kouwer, Roel Hammink	1
4	CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells 2023 ·BIO-PROTOCOL ·Camille M. Le Gall, Felix L. Fennemann, (unknown), Ferenc A. Scheeren, Martijn Verdoes	3
5	Effect of Antigen Valency on Autoreactive B-Cell Targeting 2023 ·Molecular Pharmaceutics ·(unknown), (unknown), (unknown), Theresa Kissel, (unknown), Floris J. van Dalen, Martijn Verdoes, René E. M. Toes, Kimberly M. Bonger	1
6	Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion 2022 ·Journal for ImmunoTherapy of Cancer ·Camille M. Le Gall, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yusuf Dölen, I. Jolanda M. de Vries, Carl G. Figdor, Georgina Flórez‐Grau, Martijn Verdoes	13
7	Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody 2022 ·International Journal of Molecular Sciences ·Marit J van Elsas, (unknown), Alexander Bartels, (unknown), (unknown), (unknown), Carl G. Figdor, Thorbald van Hall, Sjoerd H. van der Burg, Martijn Verdoes, Ferenc A. Scheeren	4
8	Enzyme‐Activatable Chemokine Conjugates for In Vivo Targeting of Tumor‐Associated Macrophages 2022 ·Angewandte Chemie International Edition ·Nicole D. Barth, Floris J. van Dalen, Utsa Karmakar, (unknown), Lorena Mendive‐Tapia, Takanori Kitamura, Martijn Verdoes, Marc Vendrell	30
9	The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K 2019 ·Journal of the American Chemical Society ·Elma Mons, Ineke D.C. Jansen, Jure Loboda, (unknown), (unknown), Martijn Verdoes, C. A. A. VAN BOECKEL, Peter A. van Veelen, Boris Turk, Vito Türk, Huib Ovaa	79
10	Synthetic Semiflexible and Bioactive Brushes 2019 ·Biomacromolecules ·(unknown), (unknown), Jorieke Weiden, Ben Joosten, Loek J. Eggermont, (unknown), (unknown), Alessandra Cambi, Carl G. Figdor, Paul H. J. Kouwer, Martijn Verdoes, Roel Hammink, Alan E. Rowan	11
11	An efficient synthesis of a 6″-BODIPY-α-Galactosylceramide probe for monitoring α-Galactosylceramide uptake by cells 2019 ·Carbohydrate Research ·(unknown), (unknown), Yusuf Dölen, Martijn Verdoes, Mattie S. M. Timmer, Bridget L. Stocker	11
12	Cathepsin B as a potential cystatin M/E target in the mouse hair follicle 2017 ·The FASEB Journal ·Merel A.W. Oortveld, Ivonne M.J.J. van Vlijmen‐Willems, Ferry F.J. Kersten, Tsing Cheng, Martijn Verdoes, P.E.J. van Erp, Sjef Verbeek, Thomas Reinheckel, Wiljan Hendriks, Joost Schalkwijk, Patrick L.J.M. Zeeuwen	5
13	Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based Probe 2016 ·Methods in molecular biology ·Laura E. Edgington‐Mitchell, Matthew Bogyo, Martijn Verdoes	35
14	Bifunctional Probes of Cathepsin Protease Activity and pH Reveal Alterations in Endolysosomal pH during Bacterial Infection 2016 ·Cell chemical biology ·Laura E. Sanman, Wouter A. van der Linden, Martijn Verdoes, Matthew Bogyo	36
15	Detection of Intestinal Cancer by Local, Topical Application of a Quenched Fluorescence Probe for Cysteine Cathepsins 2015 ·Chemistry & Biology ·Ehud Segal, Tyler R. Prestwood, Wouter A. van der Linden, Yaron Carmi, Nupur Bhattacharya, Nimali P. Withana, Martijn Verdoes, Aida Habtezion, Edgar G. Engleman, Matthew Bogyo	69
16	An Optimized Activity-Based Probe for the Study of Caspase-6 Activation 2012 ·Chemistry & Biology ·Laura E. Edgington‐Mitchell, Bram J. van Raam, Martijn Verdoes, (unknown), Guy S. Salvesen, Matthew Bogyo	49
17	Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors 2010 ·Journal of Biological Chemistry ·Michael Screen, (unknown), Sondra L. Downey-Kopyscinski, Martijn Verdoes, (unknown), Annet E. M. Blom, Paul P. Geurink, Martijn Risseeuw, Bogdan I. Florea, Wouter A. van der Linden, Alexandre A. Pletnev, Herman S. Overkleeft, Alexei F. Kisselev	55
18	Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit β5t 2010 ·Chemistry & Biology ·Bogdan I. Florea, Martijn Verdoes, Nan Li, Wouter A. van der Linden, Paul P. Geurink, Hans van den Elst, (unknown), Arnoud de Ru, Peter A. van Veelen, Keiji Tanaka, Katsuhiro Sasaki, Shigeo Murata, Hans den Dulk, Jaap Brouwer, Ferry Ossendorp, Alexei F. Kisselev, Herman S. Overkleeft	70
19	Selective Inhibitor of Proteasome's Caspase-like Sites Sensitizes Cells to Specific Inhibition of Chymotrypsin-like Sites 2009 ·Chemistry & Biology ·(unknown), (unknown), Sondra L. Downey-Kopyscinski, Michael Screen, Alexandre A. Pletnev, Martijn Verdoes, Robert Tokhunts, Omar Amir, (unknown), (unknown), Dennis L. Wright, Herman S. Overkleeft, Alexei F. Kisselev	144
20	A Fluorescent Broad-Spectrum Proteasome Inhibitor for Labeling Proteasomes In Vitro and In Vivo 2006 ·Chemistry & Biology ·Martijn Verdoes, Bogdan I. Florea, Victoria Menéndez-Benito, Christa J. Maynard, Martin D. Witte, Wouter A. van der Linden, Adrianus M. C. H. van den Nieuwendijk, (unknown), Celia R. Berkers, Fijs W. B. van Leeuwen, Tom A. Groothuis, Michiel A. Leeuwenburgh, Huib Ovaa, Jacques Neefjes, Dmitri V. Filippov, Gijsbert A. van der Marel, Nico P. Dantuma, Herman S. Overkleeft	163

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact